lutetium has been researched along with 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, A; Cheng, Z; Cutler, CS; Hoppmann, S; Jiang, H; Liu, H; Miao, Z; Qi, S | 1 |
Biricova, V; Hermann, P; Laznicek, M; Laznickova, A | 1 |
2 other study(ies) available for lutetium and 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
Article | Year |
---|---|
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
Topics: Amino Acid Sequence; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Copper; ErbB Receptors; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Mice, Nude; Models, Molecular; Molecular Sequence Data; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Serum Albumin; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: radiolabeling and biodistribution studies.
Topics: Animals; Chelating Agents; Dendrimers; Heterocyclic Compounds, 1-Ring; Isotope Labeling; Lutetium; Male; Pyridines; Radioisotopes; Rats; Rats, Wistar | 2014 |